Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone.
Mol Psychiatry. 2023 Dec 25. doi: 10.1038/s41380-023-02353-z. Online ahead of print.
Mol Psychiatry. 2023.
PMID: 38145984
Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability.
Levinstein MR, Carlton ML, Di Ianni T, Ventriglia EN, Rizzo A, Gomez JL, Budinich RC, Shaham Y, Airan RD, Zarate CA Jr, Bonaventura J, Michaelides M.
Levinstein MR, et al. Among authors: ventriglia en.
Biol Psychiatry. 2023 Jun 15;93(12):1118-1126. doi: 10.1016/j.biopsych.2022.12.019. Epub 2022 Dec 24.
Biol Psychiatry. 2023.
PMID: 36841701
Item in Clipboard
6-O-(2-[18F]Fluoroethyl)-6-O-Desmethyl-Diprenorphine ([18F]FE-DPN) Preferentially Binds to Mu Opioid Receptors In Vivo.
Levinstein MR, Ventriglia EN, Gomez JL, Budinich RC, Marton J, Henriksen G, Holt DP, Dannals RF, Pomper MG, Zarate CA Jr, Bonaventura J, Michaelides M.
Levinstein MR, et al. Among authors: ventriglia en.
Mol Imaging Biol. 2023 Apr;25(2):384-390. doi: 10.1007/s11307-022-01767-5. Epub 2022 Aug 23.
Mol Imaging Biol. 2023.
PMID: 35999424
Item in Clipboard
Cite
Cite